Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Southern Africa Tomorrow MSF launches an innovative drug-resistant #TB clinical trial in #SouthAfrica. This is aimed at finding treatment regimens for multi-drug resistant #tuberculosis (MDR-TB) that are shorter, less toxic and more effective than current treatme... 04:19 - 16 May 2018